SNP Technologies for Drug Discovery: A Current Review
Journal:
Current Drug Discovery Technologies
Volume:
5
Page:
230-235
Author(s):
Joanne Voisey and Charles Phillip Morris
RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
Journal:
Current Drug Discovery Technologies
Volume:
5
Page:
263-268
Author(s):
Kosei Ando, Kanji Mori, Francoise Redini and Dominique Heymann
Editorial [Hot topic:Targeted Alpha Particle Therapy (Guest Editors: Ganesan Vaidyanathan and Roy Larsen)]
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
125-126
Author(s):
GANESAN VAIDYANATHAN and ROY H. LARSEN
Commercial Availability of Alpha-Emitting Radionuclides for Medicine
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
127-134
Author(s):
Darrell R. Fisher
Production of Alpha Emitters for Targeted Alpha Therapy
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
135-143
Author(s):
A. Morgenstern, K. Abbas, F. Bruchertseifer and C. Apostolidis
Astatine Radiopharmaceuticals: Prospects and Problems
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
177-196
Author(s):
Ganesan Vaidyanathan and Michael R. Zalutsky
Treatment of Diffuse-Type Gastric Cancer Cells Using 213Bi-Radioimmunoconjugates In Vitro and In Vivo Following Intraperitoneal Dissemination
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
215-224
Author(s):
Christof Seidl and Reingard Senekowitsch-Schmidtke
Radioimmunotherapy of Infection with 213Bi-Labeled Antibodies
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
234-239
Author(s):
Ekaterina Dadachova
New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
240-250
Author(s):
Barry J. Allen, Chand Raja, Syed M.A. Rizvi, Peter Graham and John H. Kearsley
Targeted α-Particle Therapy: A Clinical Overview
Journal:
Current Radiopharmaceuticals
Volume:
1
Page:
251-253
Author(s):
Massimo Salvatori, Luca Indovina and Luigi Mansi